Tag: Pharma Industry

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Business Consultant, DelveInsight's Drug Report, Notizia, Oncology based Indications, Pharma Consultant, The Business Cocktail

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay...

Read More

Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod; Alkermes buys Rodin

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases....

Read More

Parkinson’s and tuberculosis shares a common protein that could provide better drugs for both

Business Consultant, Pharma Consultant, Snippets • One Comment

A group of researchers has recently discovered that an immune mechanism responsible in clearing bacterial infections may also be involved...

Read More

Potential cure for Common cold

Articles, Business Consultant, Pharma Consultant

A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold by...

Read More

ATTR Amyloidosis: Lack of effective treatment in the market

Articles, Business Consultant, Pharma Consultant

Amyloidoses is an umbrella term depicting the disorders that are related to protein conformation and metabolism. It occurs because of...

Read More

Nonalcoholic Steatohepatitis (NASH): Highly Epidemic

Articles, Business Consultant, Pharma Consultant

Obesity and diabetes are a global epidemic contributing to an increasing prevalence of related systemic disorders, including non-alcoholic...

Read More
Close